Research / JBL / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-19-186025 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
47.78% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.11% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.08% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
12.85% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
51.49% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
7.23% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
2.30% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.19% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.24% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Nov 30, 2019 0/9 normalized Level 3 Feb 29, 2020 8/9 normalized Level 3 May 31, 2020 8/9 normalized Level 3 Aug 31, 2020 8/9 normalized Level 3 Nov 30, 2020 8/9 normalized Level 3 Feb 28, 2021 9/9 normalized Level 3 May 31, 2021 9/9 normalized Level 3 Aug 31, 2021 9/9 normalized Level 3 Nov 30, 2021 9/9 normalized Level 3 Feb 28, 2022 9/9 normalized Level 3 May 31, 2022 9/9 normalized Level 3 Aug 31, 2022 9/9 normalized Level 3 Nov 30, 2022 9/9 normalized Level 3 Feb 28, 2023 9/9 normalized Level 3 May 31, 2023 9/9 normalized Level 3 Aug 31, 2023 9/9 normalized Level 3 Nov 30, 2023 9/9 normalized Level 3 Feb 29, 2024 9/9 normalized Level 3 May 31, 2024 9/9 normalized Level 3 Aug 31, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 43.80%
Current 47.78%
Delta 3.98% Capex Intensity Decreased
Previous 5.04%
Current 4.11%
Delta -0.93% Cash Generation Decreased
Previous 3.29%
Current 0.08%
Delta -3.21% Growth Decreased
Previous 14.45%
Current 12.85%
Delta -1.60% Inventory Pressure Decreased
Previous 53.54%
Current 51.49%
Delta -2.05% Margin Decreased
Previous 7.50%
Current 7.23%
Delta -0.26% Profitability Decreased
Previous 2.54%
Current 2.30%
Delta -0.24% R And D Intensity Increased
Previous 0.17%
Current 0.19%
Delta 0.02% Sbc Intensity Decreased
Previous 0.26%
Current 0.24%
Delta -0.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.